More than half of patients with mild COVID-19 reported symptoms months later in one study, while another found psychiatric and neurologic consequences were similar in ICU survivors with and without COVID-19. Other research looked at the rise in alcohol-related deaths and the safety of vaccination during pregnancy.
29 Mar 2022
A fourth vaccine dose increased antibodies but didn't significantly reduce infections in an Israeli study. Antibody response is similar with the stealth variant and with the original omicron variant, a small study showed. Other research found that a rapid antigen test caught most omicron infections, and the vaccines weren't associated with neurological conditions.
22 Mar 2022
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
1 May 2020
Virtual visits reduce travel time to appointments, saves out-of-pocket costs, offers better access to remote patients, and even allows physicians to see more patients while enjoying more flexible schedules.
1 Oct 2020
Experts believe practicing physicians are well positioned to take a lead role combating one of the biggest anticipated obstacles to widespread vaccination: vaccine hesitancy.
1 Jan 2021
Other recent research on COVID-19 revealed the high transmissibility of the omicron stealth variant and changes in the brain after SARS-CoV-2 infection.
15 Mar 2022
Real-time continuous glucose monitoring is seeing a real-world trial after the FDA stated it would not object to its use during the COVID-19 pandemic
1 Mar 2021
A panel of experts offered advice on avoiding drug-drug interactions when prescribing nirmatrelvir-ritonavir for patients with COVID-19, and two studies offered good news about postdischarge outcomes in COVID-19 patients who underwent a tracheostomy.
1 Mar 2022
Optimizing your telemedicine practice, or even starting it as part of your response to the COVID-19 pandemic, doesn't have to be a frantic process.
1 May 2020
The first case of Middle East Respiratory Syndrome (MERS) has been reported in the United States. This issue has been followed closely by the Centers for Disease Control (CDC) and the Department of Health and Human Services (HHS) over the past several months, as its arrival in the U.S. and its 30% mortality rate have raised the level of attention and concern.
6 May 2014